AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,769,000 | -38.6% | 188,200 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $2,880,000 | +18.9% | 376,400 | -3.9% | 0.01% | 0.0% |
| Q1 2020 | $2,422,000 | -25.0% | 391,800 | +47.6% | 0.01% | -14.3% |
| Q4 2019 | $3,230,000 | +5.3% | 265,400 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $3,066,000 | +14.1% | 265,400 | -1.3% | 0.01% | +20.0% |
| Q2 2019 | $2,688,000 | +43.2% | 269,000 | +84.6% | 0.01% | -28.6% |
| Q1 2019 | $1,877,000 | +41.3% | 145,700 | +66.7% | 0.01% | +16.7% |
| Q4 2018 | $1,328,000 | -29.1% | 87,400 | -6.6% | 0.01% | -14.3% |
| Q3 2018 | $1,872,000 | +225.6% | 93,600 | +217.3% | 0.01% | +250.0% |
| Q2 2018 | $575,000 | -76.8% | 29,500 | -64.1% | 0.00% | -81.8% |
| Q4 2015 | $2,482,000 | -19.5% | 82,200 | +5.9% | 0.01% | -15.4% |
| Q3 2015 | $3,083,000 | -14.1% | 77,600 | +49.2% | 0.01% | -7.1% |
| Q2 2015 | $3,591,000 | +44.7% | 52,000 | +14.5% | 0.01% | +40.0% |
| Q1 2015 | $2,482,000 | +24.2% | 45,400 | -3.2% | 0.01% | +25.0% |
| Q4 2014 | $1,999,000 | – | 46,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |